跳到正文
原文
Journal of Clinical Oncology 临床肿瘤· James M. Cleary·· 2026-10-02精选AI 评分85

Zenocutuzumab治疗晚期NRG1融合阳性胆管癌eNRGy II期试验的有效性与耐受性结果

Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion–Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial

AI 导读

该研究发表于Journal of Clinical Oncology,报道了eNRGy II期试验中Zenocutuzumab在晚期NRG1融合阳性胆管癌中的疗效与耐受性结果。

来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org